Theradiag SA risk profile
73 Stretched several inputs deteriorating together
Measured 21 October 2026 from ALTHE's filed statements. Recomputed nightly.
73 (Stretched), driven by Competitive position at 87, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 73 | Stretched | Volatile | One-year price volatility — 97.2% |
| Operating pressure | 38 | Normal | Easing | Operating-margin drift — -30.1 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 85 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 87 | Acute | Stable | Operating-margin gap against peers — -516.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.